The New Paper

June 18, 2021

Biden administration to invest $3 billion in antivirals

The Biden administration announced plans to invest $3B in the discovery, development, and manufacturing of antiviral medications for the coronavirus and future virus threats. The effort will be coordinated across several federal agencies (including the HHS, NIH, and NIAD) and will aim to build “sustainable platforms for discovery and development of antivirals for other viruses with pandemic potential.”
This story is from the June 18, 2021 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.